Banner Slide

Going further to bring better days to even more people with cancer

Our Business

The Helsinn Group is one of the world's leading supportive cancer care companies, with a comprehensive portfolio of medicines and therapies helping to improve the lives of patients in countries around the world.

Learn more

Corporate Social Responsibility and Sustainability

Sustainability is becoming an increasingly central part of Helsinn’s culture and business strategy. Integrity, quality and respect have always been at the core of our business, but increasingly, organisations are aware that they function as part of an ecosystem to which they have a responsibility. Care for the communities in which we operate, and stewardship of our environment, are as important to our long-term future as the economic bottom line.

Learn more

Our Products

The strength of the Helsinn model is reflected in the product candidates that we have transformed into sustainable market successes.

Learn more

Our Building Blocks

News & Events

Winners of the second annual Lyfebulb-Helsinn Innovation Summit & Awards in Onco...

Mihir Shah of UE LifeSciences Inc. has been selected as the winner of the 2019 Lyfebulb-Helsinn Innovation Award in Onco...

Read more

Helsinn initiates two new global Phase III studies with anamorelin

Helsinn committed to anamorelin which is being evaluated for weight loss and anorexia in patients with advanced non smal...

Read more

Ten finalists have been chosen for the second annual Lyfebulb-Helsinn Innovation...

The Award recognizes Patient Entrepreneurs’ innovations for cancer and cancer supportive care using therapeutics, diagno...

Read more